Veradigm (NASDAQ:MDRX) Trading Up 8.9% – Should You Buy?

Veradigm Inc. (NASDAQ:MDRX) shares were up 8.9% on Wednesday . The stock traded as high as $4.90 and last traded at $4.90. Approximately 11,749 shares traded hands during trading, a decline of 93% from the average daily volume of 167,985 shares. The stock had previously closed at $4.50.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Veradigm Trading Up 7.4%

The company has a market capitalization of $614.04 million, a P/E ratio of 23.25 and a beta of 0.55. The firm’s 50 day moving average price is $4.61 and its two-hundred day moving average price is $4.65.

Veradigm Company Profile

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.